Business

According to Pulmatrix, the Cystic Fibrosis Foundation Therapeutics (CFFT) will provide funds to support non-clinical development of PUR1900, an itraconazole DPI, for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis and asthma patients. The amount of the award was not specified by Pulmatrix; however, the CFFT website says that … [Read more...] about Pulmatrix gets development award from Cystic Fibrosis Foundation Therapeutics for PUR1900

Ascend Therapeutics is now promoting Egalet's Sprix ketorolac tromethamine nasal spray for the treatment of moderate-to-moderately severe pain to women's healthcare providers in the US, Egalet said. According to Egalet, the companies signed the agreement allowing Ascend to promote the product in July 2017. Egalet Chief Commercial Officer Patrick Shea commented, … [Read more...] about Ascend Therapeutics now promoting Egalet’s Sprix nasal spray in the US

Dance Biopharm announced that it has bought back the Asia license for its Dance-501 soft mist inhaled insulin by purchasing the license holder, Harmony Biopharm Limited, from Harmony Plus Holdings Limited (Harmony). Dance said that Harmony will receive stock and a percentage of future sales of the product in China and that Harmony will continue to advise Dance on … [Read more...] about Dance Biopharm buys back Asia license for Dance-501 inhaled insulin

Hong Kong-based Lee's Pharmaceutical will advance Windtree Therapeutics up to $3.9 million through the end of October 2017 during negotiations for Lee's to acquire a controlling interest in Windtree. The first installment of the loan has already been received by Windtree, the company said. In June 2017, Windtree announced that Lee's had acquired the rights to … [Read more...] about Lee’s Pharmaceutical to acquire controlling interest in Windtree Therapeutics

Adherium has now manufactured and sold 100,000 of its Smartinhaler inhaler monitoring devices, the company has announced. According to Adherium, the Smartinhaler has been sold in more than 40 countries to date. The Smartinhaler platform received FDA 510(k) clearance in 2014 and is currently being used in the myAirCoach project in Europe. In 2015, Adherium … [Read more...] about Adherium announces sale of 100,000th Smartinhaler

Aradigm Corporation has received a 2-year Small Business Initiative Research (SBIR) grant of about $972,000 from the National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health (NIH) for development of Linhaliq and Lipoquin to treat pulmonary non-tuberculous mycobacteria (NTM) infections, the company said. The grant will support … [Read more...] about Aradigm gets SBIR grant for development of Linhaliq and Lipoquin for NTM

According to Verona Pharma's mid-year update, the company is developing MDI and DPI formulations of its RPL554, an inhaled PDE3/PDE4 inhibitor. Nebulized RPL554 is currently in Phase 2 development, and Verona reported positive results from a Phase 2a trial of RPL554 for the treatment of acute exacerbations in COPD patients in March 2016. The company said that it … [Read more...] about Verona Pharma developing MDI and DPI formulations of RPL554

Innovus Pharmaceuticals says that it has ordered 220,000 units of FlutiCare, an OTC fluticasone propionate nasal spray, in preparation for its US launch in the fourth quarter of 2017. The company says that it will launch a 120 spray version of the product for the treatment of allergic rhinitis. Innovus acquired the FlutiCare brand in 2015 when it acquired Novalere … [Read more...] about Innovus Pharma preparing fo upcoming launch of FlutiCare nasal spray in US

Endo Pharmaceuticals filed suit against Lupin on July 28, 2017 alleging infringement of patents related to Par's Nascobal cyanocobalamin nasal spray. The suit was filed in the United States District Court for the Eastern District of Texas and was assigned to Judge Rodney Gilstrap. The patents cited in the suit include US patents 7,229,636; 7,404,489; 7,879,349; … [Read more...] about Endo files suit against Lupin for infringement of Nascobal nasal spray patents